Forward Citations = 189

Loading Chart...

3 inventors (with patents filed for the assignee):

Alan L Epstein (4 out of 33 patents)

Leslie A Khawli (2 out of 6 patents)

Clive R Taylor (2 out of 14 patents)

4 patents: Sort by Forward Citations

1. 6071491 - Detection of necrotic malignant tissue and associated therapy (2000-06-06),

2. 6017514 - Detection of necrotic malignant tissue and associated therapy (2000-01-25),

3. 5990286 - Antibodies with reduced net positive charge (1999-11-23),

4. 5194594 - Modified antibodies (1993-03-16),

Company Overview

Techniclone, Inc. is a biotechnology company that specializes in the development and commercialization of novel cancer therapies. With a focus on monoclonal antibodies and targeted therapies, Techniclone is dedicated to advancing the field of oncology through innovative research and development. The company's mission is to provide patients with cutting-edge treatments that improve outcomes and quality of life.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

4 Patents

#46 in Tustin, CA

#14,051 in California

#60,641 in US

Tustin, CA, United States of America

Techniclone, Inc.

Forward Citations = 189

3 inventors:

Alan L Epstein (4 out of 33 patents)

Leslie A Khawli (2 out of 6 patents)

Clive R Taylor (2 out of 14 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Techniclone, Inc.. Retrieved from https://idiyas.com/company/techniclone

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]